Evolva

Type: Product

Name: Evolva

First reported May 24 2013 - Updated May 24 2013 - 2 reports

Innovative Companies and Investment Trends in Clean Tech at BIO World Congress

A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of ... [Published Advanced Biofuels and Climate Change Informatio ... - May 24 2013]

Entities: Clean Technology, Brent Erickson, Biotechnology, Evolva, Renewable Chemicals

First reported May 10 2013 - Updated May 10 2013 - 1 reports

WANdisco Plc

Investment Research Weekly Roundup including: President Energy,Afferro Mining and WANdisco

CML Microsystems Update - Profit beat and raise 09 May 2013 In an unscheduled trading update, CML has announced that full-year PBT will be 10% ahead of our forecast, at £5.0m, on revenues slightly ahead of forecasts. Net cash is also substantially ... [Published Proactiveinvestors United Kingdom RSS feed - May 10 2013]

Entities: WANdisco Plc, Evolva, Afferro Mining Inc

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Cargill Inc

Edison - Evolva - Licensing deal and fund-raising - Life is sweet

Home » Blogs » The co-development deal for stevia with Cargill and the CHF31.3m equity raise in March have transformed the prospects of Evolva. In Cargill, Evolva has the ideal partner to maximise the potential of its most valuable programme. Evolva could ... [Published BioPortfolio - May 08 2013]

Entities: Evolva, Stevia, Cargill Inc

First reported May 05 2013 - Updated May 05 2013 - 1 reports

PepsiCo Inc

Soft Drink Earnings Reveal Need For Change

Flat volume growth for Coke and Pepsi has both beverage giants looking for answers to future growth.Coca-Cola (KO) the world's biggest beverage maker, announced first-quarter results last week. Both revenues and profit were down year-over-year. Similarly, ... [Published Seeking Alpha - May 05 2013]

Entities: Stevia, Coca-Cola, PepsiCo Inc, Pepsi

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Evolva

[Evolva] rights offering grosses CHF31.3mm

Home » Blogs » [Evolva Holding SA] (yeast- and fermentation-based technology for small-molecule drug production) grossed CHF31.3mm ($33mm) through a fully subscribed rights offering. A total of 52mm shares were issued to existing stockholders--who could ... [Published BioPortfolio - Apr 19 2013]

Entities: Evolva, Evolva Holding SA, Biotechnology

First reported Apr 12 2013 - Updated Apr 12 2013 - 1 reports

Synthetic anti-malaria compound is bad news for artemisia farmers | Jim Thomas

Artemisinin breakthrough by synthetic biologists threatens to open new front in battle between microbes and peopleIn the constant fight between microbes and people, attempts to rein in the malarial parasite have just taken an interesting turn. On Thursday ... [Published Guardian.co.uk - Apr 12 2013]

Entities: Jay Keasling, Microbe, Malaria, Yeast

Quotes

More From BioPortfolio on "Edison - Evolva - Licensing deal and fund-raising - Life is sweet"

Edison - Evolva - Licensing deal and fund-raising - Life is sweet [Published BioPortfolio - May 08 2013]

...Asked whether this means that all natural artemesia production will be replaced, he said: "Early onon it was not about replacing the agricultural form … and now I think it's nearly inevitable that it will shift over." Keasling proffered that artemesia farmers might switch to growing wheat and potatoes instead

Synthetic anti-malaria compound is bad news for artemisia farmers | Jim Thomas [Published Guardian.co.uk - Apr 12 2013]

More Content

sort by: Date \| Relevance
Innovative Companies and Investment Trends in C... [Published Advanced Biofuels and Climate Change Informatio ... - May 24 2013]
Innovative Companies and Investment Trends in C... [Published I Am Biotech - May 24 2013]
Investment Research Weekly Roundup including: P... [Published Proactiveinvestors United Kingdom RSS feed - May 10 2013]
Edison - Evolva - Licensing deal and fund-raisi... [Published BioPortfolio - May 08 2013]
International Flavors & Fragrances Management D... [Published Seeking Alpha - May 07 2013]
Soft Drink Earnings Reveal Need For Change [Published Seeking Alpha - May 05 2013]
The Rise and Rise of Superbugs – so how do we f... [Published pharmaphorum - Apr 25 2013]
The Influence of Smoking Status on the Pharmaco... [Published Journal of the American College of Cardiology - Apr 25 2013]
Gentical Raises $23.7M From Wellington, EdRIP, ... [Published PE Hub News - Apr 24 2013]
[Evolva] rights offering grosses CHF31.3mm [Published BioPortfolio - Apr 19 2013]
Synthetic anti-malaria compound is bad news for... [Published Guardian.co.uk - Apr 12 2013]
Wellington Partners Life Science Team Hires Ven... [Published PE Hub News - Mar 26 2013]
Evolva And Cargill In Deal To Co-develop Stevio... [Published EON Health & Medicine - Mar 06 2013]
Evolva And Cargill In Deal To Co-develop Stevio... [Published EON Science - Mar 06 2013]
Evolva And Cargill In Deal To Co-develop Stevio... [Published Business Wire Health News - Mar 06 2013]
IFF and Evolva Enter Pre-Production Phase for N... [Published Business Wire Retail News - Feb 05 2013]
IFF and Evolva Enter Pre-Production Phase for N... [Published Business Wire Photo/Multimedia News - Feb 05 2013]
IFF and Evolva Enter Pre-Production Phase for N... [Published Business Wire Manufacturing News - Feb 05 2013]
IFF and Evolva Enter Pre-Production Phase for N... [Published Business Wire News with Multimedia - Feb 05 2013]
ABLE and Invest in Denmark to organise seminar ... [Published PharmaBiz - Aug 25 2012]